Home » Stocks » SPEL

Spinal Elements Holdings, Inc. (SPEL)

Spinal Elements was planning to go public, but the IPO has been postponed.
Stock Price: $13.00 - $15.00
Current IPO price range

Stock Price Chart

Key Info

Market Cap 386.20M
Revenue (ttm) 92.56M
Net Income (ttm) -48.09M
Shares Out 27.59M
EPS (ttm) -1.74
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day n/a
Last Price n/a
Previous Close n/a
Change ($) n/a
Change (%) n/a
Day's Open n/a
Day's Range n/a
Day's Volume n/a
52-Week Range n/a

More Stats

Market Cap 386.20M
Enterprise Value n/a
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 27.59M
Float n/a
EPS (basic) n/a
EPS (diluted) -1.74
FCF / Share n/a
Dividend n/a
Dividend Yield n/a
Earnings Yield -12.45%
FCF Yield n/a
Payout Ratio n/a
Shares Short n/a
Short Ratio n/a
Short % of Float n/a
Beta n/a
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 4.17
PB Ratio n/a
Revenue 92.56M
Operating Income n/a
Net Income -48.09M
Free Cash Flow n/a
Net Cash n/a
Net Cash / Share n/a
Gross Margin n/a
Operating Margin n/a
Profit Margin -51.95%
FCF Margin n/a
ROA n/a
ROE n/a
ROIC n/a
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Forecasts

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

$n/a*
*No analysts have provided price targets for this stock.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year20192018
Revenue95.9290.75
Revenue Growth5.69%-
Net Income / Loss-51.42-53.46
Numbers in millions USD.

Company Profile

Company Details

Full Name Spinal Elements Holdings, Inc.
Country United States
Employees 120
CEO Jason Blain

Stock Information

Ticker Symbol SPEL
Stock Exchange NASDAQ
Industry Health Care / Medical Devices
Unique Identifier NASDAQ: SPEL
IPO Date January 1, 1970

Description

Spinal Elements is a medical device company focused on the design, development and commercialization of a comprehensive portfolio of systems, products and technologies for spine surgery procedures, with a strategic focus on minimally invasive surgery (“MIS”) procedures. We are an innovation-driven company with a track-record of delivering pioneering and differentiated products and technologies. Our product portfolio addresses a broad spectrum of spine surgery procedures and consists of innovative spinal fixation systems (implantable hardware systems that are mechanically attached to the spine and provide stability), interbody implants (devices implanted between the vertebral bodies of the spine), surgical instruments (instruments used to prepare the spine and implant our devices) and biologics (allograft or synthetic biomaterials intended to augment or replace the normal capacity of such tissue in the body). We offer a comprehensive product portfolio that can address approximately 95% of the spine surgery procedures performed worldwide in 2018 and our systems, products and technologies cover a wide variety of spine disorders, including degenerative conditions, deformities and trauma. We expect to continue to complement our existing product portfolio with new product offerings based on innovative technologies. We believe our comprehensive product portfolio has the potential to enhance the way surgeons operate and to disrupt the spine surgery market.